AdvaMed® 2024 State Policy Briefing: State Data Privacy Legislation
AdvaMed® held a panel discussion with partners at the International Pharmaceutical & Medical Device Privacy Consortium (IPMPC) on U.S. State Privacy Legislation.
Forging a New Data Paradigm in MedTech
AdvaMed® partners with IQVIA for this free webinar to discuss forging a new data paradigm in MedTech.
Creating an Automated Test Strategy and Framework for Regulated Medical Device Software
Join GlobalLogic and AdvaMed® for an insightful webinar on all aspects of creating an automating software testing system.
Taking the Road More Travelled: Applying Enterprise Technology Best Practices to MedTech
Discover how to adopt and apply innovative technologies to your organization by taking the road more travelled and learning from the experience of other industries.
Building Connected Care: Working with Providers and Enabling as a Service Business Models – A Chat with Jaime Osborn, XaaS Business Innovation Leader
Join Deloitte and AdvaMed® for an insightful webinar on redefining the medtech industry through ‘connected care.’
Innovation and Safety: The Unique Challenges of Complex Safety-Critical Medical Device
Join Sunrise Labs and AdvaMed® for this insightful webinar on medical product development best practices.
Advancing Medtech’s Digital Opportunity to Meet the Moment
Join EY and AdvaMed® for this insightful webinar on the current state of the medtech industry and where it’s headed.
Medical Device Submissions Workshops
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
The Machines Are Coming (And Lawsuits Too): Mitigating Risks of Device Design, Manufacture, and Sale Amidst the AI Revolution
Explore the latest regulatory trends impacting AI and machine learning-enabled medtech devices in this free webinar.
China Medical Device Webinar with AdvaMed Accel® for U.S. Exporters
Join us for a breakdown of the Chinese medical device market, to review the current regulatory requirements and pathways, and address I.P. protection in China for U.S. companies.